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Abstract 24 
Kefir is a mixed fermented product with numerous attributed health benefits due to 25 
presence of a complex culture composed of bacteria and yeasts in an 26 
exopolysaccharide matrix. This work aimed at isolating and identifying culturable yeast 27 
species from two types of traditional kefir grains and establishing some potential 28 
probiotic properties including survival in the gastrointestinal tract, auto-aggregation, 29 
hydrophobicity and hydrolytic enzymes production. All the isolates showed good 30 
survival rates in simulated gastrointestinal tract solution, with <0.5 log10 reduction. 31 
Kluyveromyces lactis was characterized with a high level of hydrophobicity (88.75%) 32 
but moderate auto-aggregation whereas S. unisporus showed moderate 33 
hydrophobicity and auto-aggregation. Indicator enteric bacteria adhered onto both 34 
viable and non-viable yeast isolates and controls. In comparison to Saccharomyces 35 
boulardii strains used as controls, both kefir yeast strains showed low alpha hemolytic 36 
and proteolytic activities, but exhibited no phospholipase activity. Kluyveromyces lactis 37 
and Saccharomyces unisporus isolated, were identified on the basis of 26s rDNA and 38 
ITS region sequencing. Overall, the yeast isolates showed some potential probiotic 39 
properties. 40 
 41 
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1. Introduction 44 
Kefir is an acidic and low alcoholic probiotic product made from kefir grain, which is a 45 
consortium of exopolysaccharides and many microorganisms (Plessas et al., 2016; 46 
Prado et al., 2015). The term kefir is derived from kef, a Turkish word which is 47 
translated as ‘pleasant taste’ (Arslan, 2015). Chemically, kefir grains are generally 48 
composed of 890-900 g/kg water, 2 g/kg fat, 30 g/kg protein, 60 g/kg sugars and 7 g/kg 49 
ash, and these may vary depending on the grain. Physically, grains appear as 50 
cauliflower florets with size ranging from 0.3 to 3.5 cm in diameter (Garrote, Abraham, 51 
& De Antoni, 1997). Bacterial components of kefir grains include Lactobacillus, 52 
Lactococcus, Leuconostoc and Streptococcus genera while yeast genera include 53 
Kluyveromyces, Candida, Saccharomyces and Pichia (Plessas et al., 2016). Spatial 54 
distribution of microorganisms in kefir is still controversial, however, it has been  55 
generally reported that yeasts are located in the inner and intermediate inner section 56 
of the grains while bacteria exist on the surface areas  of grains (de Oliveira Leite et 57 
al., 2013). Kefir can be produced commercially using two-step fermentation process 58 
(Russian method) or traditional one-step fermentation method by inoculating milk, fruit 59 
juices or molasses with kefir grains (Plessas et al., 2016).  60 
Kefir is widely consumed in Caucasus Mountains of Russia, Europe, Asia, South and 61 
North America for health benefits conferred by probiotic microorganisms (Plessas et 62 
al., 2016). Probiotics are defined by the World Health Organization (WHO) and Food 63 
and Agriculture Organization (FAO) as ‘live microorganisms which when administered 64 
in adequate amounts confer a health benefit on the host’ (FAO/WHO, 2002). Kefir 65 
consumption has been associated with benefits in management and treatment of 66 
gastrointestinal problems, hypertension, allergies, cancers, and ischemic heart 67 
disease. Furthermore, antibacterial properties against pathogenic bacteria such as 68 
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Salmonella have been reported (Zavala et al., 2016). These prophylactic and 69 
therapeutic properties are associated with probiotic microorganisms’ interactions with 70 
the hosts. Moreover, probiotics prophylactic and therapeutic properties are also 71 
attributed to their bioactive metabolites including organic acids, bacteriocins, carbon 72 
dioxide, hydrogen peroxide, ethanol and diacetyl (de Oliveira Leite et al., 2013).  73 
Probiotics are expected to meet certain criteria including; the ability to persist and 74 
multiply in the gastrointestinal tract (GIT) (resistance to acidic gastric juice, basic 75 
pancreatic juice, lysozyme, and bile salts), ability to auto-aggregate and to form normal 76 
sustaining flora, and should be non-pathogenic (Gut, Vasiljevic, Yeager, & Donkor, 77 
2018). Proteinases, phospholipases and hemolysins are some of the key hydrolytic 78 
enzymes that may contribute to invasiveness, persistent infections, host immune 79 
evasion, proliferation and colonization, as well as provision of nutrients to pathogenic 80 
yeasts such as C. albicans (Anoop, Rotaru, Shwed, Tayabali, & Arvanitakis, 2015; 81 
Ramesh et al., 2011). However, some of these hydrolytic enzymes may be beneficial 82 
in treatment of proteinous toxins producing bacteria (Gut et al., 2018). 83 
This work thus was focused on isolating, identifying and characterizing the culturable 84 
kefir yeasts from two traditional kefir grains. The isolates were examined for GIT 85 
survival, auto-aggregation, growth at 37 °C, hydrophobicity, antibacterial properties as 86 
well as screened for hydrolytic enzymes including proteolysins, phospholipases and 87 
hemolysins. 88 
2. Materials and methods 89 
2.1. Isolation and enumeration of yeast isolates 90 
Kefir grains were obtained from the Werribee starter culture collection (Victoria 91 
University, Melbourne, Australia). They had two origins - kefir grain coded TVR was 92 
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originally from Russia while the other grain coded HSK originated from Kazakhstan. 93 
Yeast species were isolated as previously reported with some modifications (Garofalo 94 
et al., 2015). Briefly, samples of kefir grains were initially cultivated in pasteurized milk 95 
to initiate their growth proliferation. They were subsequently removed from the 96 
fermented milk and washed with sterile water. The grain samples were inoculated into 97 
200 mL ultra-high temperature (UHT) milk (Devondale, Murray Goulburn, Melbourne, 98 
Australia), incubated at 30 °C for 24 hours, and then moved to 25 °C incubator 99 
(Thermoline, wetherill park, Australia) for further 24 hours. Ten grams of the freshly 100 
cultured (TVR and HSK) grains were diluted in 90 mL 0.1% peptone water (Oxoid, 101 
Basingstoke, United Kingdom) and each mixture was thoroughly homogenized using 102 
a BagMixer (Interscience, Saint Nom, France) for 2 minutes. Ten grams each of 103 
remaining kefir (devoid of grains) were also diluted in 90 mL of 0.1% peptone water. 104 
Serial dilutions from 10-1 to 10-5 were performed and 100 μL were inoculated onto 105 
Rose-Bengal chloramphenicol agar (RBCA, Oxoid, Basingstoke, United Kingdom). 106 
Chloramphenicol was prepared by following manufacturer’s protocols and 3 mL of 107 
sterile deionized water was added to vial and mixed thoroughly. The vial content was 108 
then added to 500 mL RBCA agar base. Chloramphenicol was added to RBCA in order 109 
to inhibit growth of bacteria component of kefir. Plates were incubated aerobically at 110 
25 °C for 5 days. Yeast growth on agar plates were counted and morphologically 111 
grouped as reported in a previous study (Garrote et al., 1997). Briefly, colonies were 112 
grouped based on color, size, form, elevation and margin, and also on the basis of cell 113 
morphology using optical microscopy (Olympus Optical, Tokyo, Japan).  Colonies from 114 
HSK and TVR were coded as HSK18099-11 and TVR18099-12 respectively. 115 
2.2. Probiotics potential evaluations 116 
2.2.1 Growth at human body temperature 117 
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 Well isolated colonies of the yeast isolates were streaked onto yeast YEPD agar and 118 
incubated at 37 °C aerobically for 10 days.  119 
2.2.2. Survival in simulated gastrointestinal tract conditions 120 
Survival of kefir yeast isolates in simulated GIT was performed as reported (Minekus 121 
et al., 2014)  with some modifications. Briefly, 10 mL of kefir yeast isolates and controls  122 
(S. boulardii SB48 MYA-796, and S. boulardii SB49 MYA-79) in YEPD broth initially 123 
incubated at 25°C for 24 hours in  a shaking incubator at 100 horizontal strokes/min  124 
(Innova 4230 New Brunswick Scientific, Edison, NJ, USA )  was added to 10 mL sterile 125 
0.1 % peptone water. The yeast mixture was serially diluted up to 10-7 using 0.1 % 126 
peptone water, 100 μL of each dilution was plated onto YEPD agar, and incubated at 127 
25 °C aerobically for 5 days. This was used as a control.  128 
Another 10 mL aliquot of the yeast cultures mentioned above were mixed with 7.5 mL 129 
of simulated gastric fluid (SGF) containing 6.9 mL KCl (0.5 M), 0.9 mL KH2PO4 (0.5 M), 130 
12.5 mL NaHCO3 (1 M), 11.8 mL NaCl (2 M), 0.4 mL MgCl2·6H2O (0.15 M) and 0.5 131 
mL (NH4)2CO3 (0.5 M). Two milliliters of 20,000 U/mL (3.7 g 543 unit/g in 100 mL sterile 132 
milli-Q water) porcine pepsin solution was added. Furthermore, 5 μL 0.3 M 133 
CaCl2 solution and 0.295 mL of water were added.  Final pH was adjusted to 3.0.  134 
Twenty milliliters of the mixtures containing yeasts were incubated at 37 °C aerobically 135 
for 2 hours in a shaking incubator as above. The simulated gastric chymes containing 136 
yeast were further mixed with 11 mL of simulated intestinal fluid (SIF). The SIF solution 137 
contained 6.8 mL KCl (0.5 M), 0.8 mL KH2PO4 (0.5 M), 42.5 mL NaHCO3 (1 M), 9.6 138 
mL NaCl (2 M), 1.1 mL MgCl2·6H2O (0.15 M), 5 mL pancreatin stock solution (800 139 
U/mL in simulated intestinal fluid electrolyte), 2.5 mL  bile salt (160 mM), 40 μL 140 
CaCl2 (0.3 M) and 1.31 mL sterile water. Final pH was adjusted to 7.0, and the 141 
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solutions were incubated at 37 °C aerobically for 2 hours in a shaking incubator at 100 142 
horizontal strokes/min.  Serial dilutions from the simulated GIT mixture were performed 143 
as above and YEPD agar was inoculated with 100 μL of each dilution and incubated 144 
at 25 °C aerobically for 5 days.   145 
2.2.3. Hydrophobicity 146 
Hydrophobicity experiment was carried out as previously described (Fadda, Mossa, 147 
Deplano, Pisano, & Cosentino, 2017a) with some modifications. Yeast cultures in 148 
YEPD broth incubated  at 25 °C for 24 hours were centrifuged (Eppendorf AG, 149 
Hamburg, Germany) at 4,000 g for 15 minutes at 4 °C and washed twice with 1X PBS. 150 
The yeast pellets were re-suspended in 1X PBS and optical density at 560 nm 151 
(OD560nm) was measured using spectrophotometer (Shimadzu, Kyoto, Japan). The 152 
yeast cultures in 1X PBS optical densities were adjusted to range between 0.4 to 1 153 
using the same buffer. Three milliliters of the yeasts suspension and 0.6 mL n-154 
hexadecane (Sigma, St. Louis, USA) were mixed and vortexed for 2 minutes before 155 
incubation at 37 °C aerobically for 1 hour to separate n-hexadecane and aqueous 156 
phases. The aqueous phase optical density of the solution was measured using 157 
spectrophotometer (Shimadzu, Kyoto, Japan) at 560 nm. Percentage hydrophobicity 158 
was calculated as a reduction in OD560nm using the formula:  159 
% hydrophobicity =    
𝑂𝐷0−𝑂𝐷
𝑂𝐷
 ×  100 160 
Where OD0 and OD are OD560nm before and after extraction with n-hexadecane 161 
respectively. 162 
2.2.4. Auto-aggregation 163 
Auto-aggregation experiment was performed as reported in the literature (Fadda et 164 
al., 2017a) with some modifications. Yeast cultures incubated in YEPD broth at 25 °C 165 
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aerobically for 24 hours were centrifuged at 4000 g for 15 minutes at 4 °C and washed 166 
twice in 3 mL 1X PBS per wash after each centrifugation. The yeast cultures in 1 X 167 
PBS optical densities were adjusted to range between 0.4 to 1 using the same buffer.  168 
OD560nm of the suspensions were measured using spectrophotometer (Shimadzu, 169 
Kyoto, Japan) before incubation at 37 °C for 2 hours. The top phase of the solution 170 
was carefully removed after incubation and OD measured again at 560nm. Percentage 171 
auto-aggregation was calculated as follows: 172 
% auto-aggregation = [1 − (𝑂𝐷𝑡
𝐷0
)] × 100 173 
Where OD is OD560nm before incubation and ODt is OD560nm after incubation. 174 
2.3. Safety screening 175 
2.3.1. Phospholipase production 176 
Phospholipase production screening was performed as described in literature 177 
(Deorukhkar, Saini, & Mathew, 2014) with some modifications. Ten microliters of yeast 178 
suspension from YEPD broth was spotted onto Sabouraud dextrose agar (SDA) plus 179 
egg yolk (16.25 g SDA,  Oxoid, Basingstoke, United Kingdom; 20 mL egg yolk 180 
emulsion, Sigma-Aldrich, Castle Hill, Australia, 230 mL sterile distilled water), with a 181 
final pH 7. Plates were incubated at 30 °C and 37 °C aerobically for up to 5 days. 182 
Phospholipase activity was expressed as ratio of diameter of colony to that of colony 183 
plus translucent zone around the colony. Diameter was measured using digital caliper 184 
(Instrument Choice, Dry Creek, Australia). C. albicans (ATCC 10231) was used as a 185 
positive control.  186 
2.3.2.   Hemolytic activity 187 
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Hemolysin production was screened as described in literature (Deorukhkar et al., 188 
2014; Luo, Samaranayake, & Yau, 2001) with some modifications. Briefly, spot 189 
inoculation with 10 μL yeasts suspension in YEPD onto SDA enriched with 7% (of final 190 
volume) sheep defibrinated blood (Oxoid, Basingstoke, United Kingdom) was 191 
performed. Final medium pH was adjusted to 5.6.  Plates were incubated at 30 °C and 192 
37 °C for up to 5 days. Hemolytic activity was expressed as ratio of diameter of colony 193 
to that of colony plus translucent or clear zone around the colony. Diameter was 194 
measured using digital caliper (Instrument Choice, Dry Creek, Australia). C. albicans 195 
was used as a positive control. 196 
2.3.3. Proteolytic activity 197 
Screening for proteolytic enzymes production was performed as previously described 198 
(AlGburi et al., 2016; Deorukhkar et al., 2014) with some modifications by spot 199 
inoculating 10 μL of yeast suspensions in YEPD broth onto SD plus milk agar (100 mL 200 
UHT skim milk,  16.25 g  SDA, and  100 mL deionized sterile water), with a final 201 
medium pH of 7.3. Plates were incubated at 30 °C and 37 °C for up to 5 days. 202 
Proteolytic activity was expressed as ratio of diameter of colony to that of colony plus 203 
clear zone around the colony. Diameter was measured using digital caliper (Instrument 204 
Choice, Dry Creek, Australia). C. albicans was used as a positive control. 205 
2.4. Identification of yeast isolates 206 
Different colony types from RBCA were picked and streaked onto yeast extract 207 
peptone dextrose (YEPD) agar (Oxoid, Basingstoke, United Kingdom) and incubated 208 
at 30 °C for 3 days. These isolates on YEPD agar were sent to Microgenetix, a National 209 
Association of Testing Authorities (NATA) accredited laboratory for identification using 210 
26s fungal ribosomal DNA. MicroSEQ® D2 LSU rDNA Fungal Identification Kit was 211 
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used as per manufacturer’s protocols (Scientific, 2015). Further identification work was 212 
performed on TVR18099-12 colonies using internal transcribed spacer (ITS) region 213 
sequencing and Accugenix ITS database (AccuBLAST) by the same laboratory as per 214 
literature (Schoch et al., 2012).  26s rDNA was previously used in identification of kefir 215 
grains yeast isolates including Saccharomyces cerevisiae, Saccharomyces unisporus, 216 
Issatchenkia occidentalis and Kluyveromyces marxianus.  (Diosma, Romanin, Rey-217 
Burusco, Londero, & Garrote, 2014). 218 
2.5. Antibacterial properties 219 
 220 
2.5.1. Growth inhibition 221 
Bacteriostatic and bactericidal analysis was performed as described in the literature  222 
(Katarzyna Rajkowska & Kunicka-Styczyńska, 2012) with some modification.  Slabs 223 
of yeasts isolates previously grown on YEPD agar at 30 °C for 24 hours  were placed 224 
on Muller-Hinton agar (Oxoid, Basingstoke, United Kingdom) previously inoculated 225 
with  104 cfu/mL Escherichia coli  ATCC 43895 ( E.coli) and Enterobacter aerogenes 226 
VUN 00025 (E. aerogenes) as spread plate and incubated at 37 °C for 24 hours.   227 
Production of antibacterial molecules or pH effects analysis was carried out as 228 
reported (Bajaj, Raina, & Singh, 2013) with modification. Fermentation was performed 229 
by growing yeast isolates and controls in killer toxin medium (KTM) consisting of YEPD 230 
plus glycerol (50 g/L, Sigma, St. Louis, USA), buffered at pH 5 using 50 mM citrate-231 
phosphate buffer, and fermented at 30 °C under shaking (180 rpm) for 24–72 hrs. 232 
Fermented broth was centrifuged (Eppendorf AG, Hamburg, Germany) at 4,000 g for 233 
30 minutes at 4 °C.  Supernatant from KTM was used for well diffusion assay as 234 
described previously (Bajaj, Raina, & Singh, 2013).  235 
2.5.2. Sedimentation and adhesion assay. 236 
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Adhesion of bacteria onto yeast cells was performed as previously described (Tiago 237 
et al., 2012) with some modification. Briefly,  1 mL (approximately 108 cfu/mL) yeast 238 
in YEPD broth initially incubated at 25 °C for 24 hours in a shaking incubator at 100 239 
horizontal strokes/min  (Innova 4230 New Brunswick Scientific, Edison, NJ, USA ) was 240 
added to a 15 mL centrifuge tube with 0.5 mL of E. coli and E. aerogenes 241 
(approximately109 cfu /mL).  The bacteria-yeast mixture was vortexed for 1 minutes 242 
and incubated at 37 °C for 4 hours. Slide agglutination was also performed and 243 
macroscopically observed. One hundred microliter aliquot of supernatant was serially 244 
diluted and plated onto Nutrient agar (Oxoid, Basingstoke, United Kingdom) 245 
supplemented with 0.1 % cycloheximide (Sigma, St. Louis, USA) to suppress yeasts 246 
growth. Plates were incubated at 37°C for 24 hours. Indicator bacterial colonies were 247 
counted and expressed as log10 cfu/mL. For the controls, 1 mL of sterile YEPD broth 248 
was added to 0.5 mL of indicator bacteria and treated as above. The procedure was 249 
repeated for non-viable yeasts sedimentation and adhesion assay after the yeasts 250 
initially grown in YEPD broth were inactivated by autoclaving at 121°C for 15 minutes.  251 
To visualize the adherence of bacteria onto yeast cells, 10 μL of the sediments were 252 
smeared onto microscopic slides. Gram stain was performed as described (Claus, 253 
1992) and analyzed under optical Motic microscope (Motic, Melbourne Australia).    254 
2.6. Statistical analysis 255 
Experiments were replicated at least twice with subsequent three subsampling. The 256 
data was analyzed with a randomized split plot block design, using replications as the 257 
block. The isolates at two levels were the main plot. All data were expressed as mean 258 
and with standard error of the mean. Statistical analysis was performed using SPSS 259 
Statistical software (IBM, New York, USA).  260 
12 
 
3.0. Results and discussions 261 
3.1. Isolation and enumeration of yeast isolates 262 
Table 1 summarizes yeast species isolated from traditional kefir product. Two distinct 263 
colony morphologies were isolated on RBCA shown in figure 1. HSK18099-11 264 
colonies morphology from both grain and kefir appeared similar, likewise, the 265 
morphology appearance of colonies for TVR. Both colony and cellular morphologies 266 
of these kefir isolates were consistent with previous study in terms of colonies and cell 267 
appearance (Garrote et al., 1997). Figure 2 shows traditional kefir grains used in this 268 
study after separation from kefir, and washed with sterile water. The appearances of 269 
the grains were consistent with the description of kefir grains in literature (Garrote et 270 
al., 1997). It appeared TVR18099-11 was readily released into kefir, hence the high 271 
cell count in kefir compared to the grain. On the other hand, HSK18099-12 was 272 
retained in the grain resulting in low cell count (Table 1). The numbers of yeasts in 273 
these traditional kefirs were similar to a previous study (Silva, Santos, Santana, 274 
Silva, & Coaceicao, 2018) which recorded 5.6 cfu/g (log10) yeasts cells in kefir drinks.  275 
3.2. Survival in simulated GIT 276 
Kefir yeast isolates and 2 strains of S. boulardii used as controls decreased by <0.5 277 
log10   under GIT simulated conditions for 4 hours (Table 2). All the kefir yeasts isolates 278 
showed high survival rates in simulated GIT conditions comparable to controls strains 279 
(SB48/MYA 796TM and SB49/MYA 797TM) currently used as prophylactic and 280 
therapeutic strains in some human ailments (Czerucka, Piche, & Rampal, 2007; 281 
Hudson et al., 2016; Palma et al., 2015). MYA 796 was the least affected yeast strain 282 
by GIT conditions, and the variation of log10 reduction may be due to strain differences. 283 
The ability of these kefir yeast isolates to survive in the GIT may be due to the fact that 284 
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kefir is an acidic and low alcohol beverage (Prado et al., 2015) and therefore have 285 
likely developed resistance to harsh conditions. HSK and TVR kefir pH were 4.7 and 286 
4.5 respectively after 48 hours of incubation as described above. Resistance of S. 287 
boulardii MYA 797 to GIT conditions has been postulated to be due to thicker cell walls 288 
compared to other Saccharomyces cerevisiae strains including W303 and BY4741 289 
(Hudson et al., 2016). However, exposure of S. boulardii MYA 797 to Caspofungin, an 290 
antifungal drug that interferes with synthesis of cell wall, was found to significantly 291 
reduce resistance of these strains to GIT simulated environment (Hudson et al., 2016). 292 
Role of cell wall thickness of kefir yeast isolates in GIT survival in this study needs 293 
further investigation. Survival in the GI tract is an important criteria for microorganisms 294 
to be classified as probiotic, and involves being able to resist acidic gastric juice such 295 
as pepsin, basic pancreatic enzymes lysozyme, and bile salts at physiological 296 
temperature (Gut et al., 2018). Survival of these yeast strains in simulated GIT showed 297 
their resistance to digestive enzymes including pepsin, pancreatins as well as bile salts 298 
and low pH. S. cerevisiae CIDCA8112 and Kluyveromyces marxianus were reported 299 
to exhibit immunomodulatory properties which depended on viability of the yeast 300 
species (Romanin et al., 2010). Furthermore, viability of yeast probiotics is associated 301 
with several antagonistic properties towards enteropathogenic bacteria including 302 
competition for nutrients, binding sites and production of  antibacterial molecules 303 
(Revolledo, Ferreira, & Ferreira, 2009).  304 
3.3. Growth at human body temperature 305 
Growth for both isolates and controls is shown in table 2. Both the controls and 306 
TVR18099-12 were able to grow at 37 °C whereas HSK18099-11 did not grow at 37° 307 
C (Table 2). This was in agreement with previous studies where some yeast species 308 
grew at 30 °C but no at 37 °C (Lodder & Kreger-Van, 1952).  Failure of HSK18099-11 309 
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to grow at this human body temperature may not disqualify it as a potential probiotic 310 
since prophylactic and therapeutic potentials of yeasts are not limited to viable and 311 
proliferating cells only. Prophylactic and therapeutic efficacy of non-viable yeast cells 312 
have been reported (Gut et al., 2018). 313 
3.4. Auto-aggregation 314 
Auto-aggregation of kefir isolates and controls are shown in table 2. It is defined as 315 
aggregation among yeast cells to form flocs or flor which provides competitive 316 
advantage over other microorganisms including enteric bacterial pathogens in a harsh 317 
environment such as human GIT (Brückner & Mösch, 2012). Auto-aggregations of 318 
kefir isolates were slightly comparable to that of S. boulardii strains used as controls. 319 
The percentage auto-aggregations of isolates and controls were consistent with 320 
previous studies (Fadda et al., 2017a; Gil-Rodríguez , Carrascosa, & Requena, 2015). 321 
Formation of cell aggregates provides shielding to cells in the center against harmful 322 
environmental conditions (Suvarna, Dsouza, Ragavan, & Das, 2018). In vitro auto-323 
aggregation can be influenced by duration of incubation used during analysis to 324 
separate aqueous and n-hexadecane phase (Gil-Rodríguez, Carrascosa, & Requena, 325 
2015). On the other hand, yeasts auto-aggregation has been reported to be strain-326 
specific (Gil-Rodríguez  et al., 2015; Suvarna et al., 2018). Therefore, variations of 327 
auto-aggregation in the current study was likely due to these factors which have 328 
similarly been reported by Fadda et al. (2017) using similar strains. 329 
3.5. Hydrophobicity 330 
Kefir yeast isolates were analyzed for hydrophobicity (Table 2). Hydrophobicity is 331 
defined as a non-specific interaction between microbial and host cells. This interaction 332 
is mediated by cell-surface proteins and lipoteichoic acids (Todorov et al., 2008). In 333 
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this study, TVR18099-12 showed significantly higher hydrophobicity and therefore 334 
was capable of interacting with other cell bodies compared to HSK18099-11 and 335 
controls. Similar findings showed significantly lower hydrophobicity for control strains 336 
compared to other strains (Fadda et al., 2017a). Hydrophobicity is crucial in adhesion 337 
of probiotic microorganisms onto GIT epithelial cells where they may provide 338 
prophylactic and therapeutic benefits (Fadda et al., 2017a). Hydrophobicity is species 339 
and strain specific as demonstrated in this study (Fadda, Mossa, Deplano, Pisano, & 340 
Cosentino, 2017b; Suvarna et al., 2018). Furthermore, similar to a previous study, 341 
there was no correlation between auto-aggregation and hydrophobicity (Fadda et al., 342 
2017a).  343 
3.6. Hydrolytic enzymes screening 344 
3.6.1. Phospholipase activity 345 
The kefir yeast isolates and probiotic controls did not produce these enzymes (Figure 346 
3). Only positive control (C. albicans) produced phospholipase hence the zone of 347 
precipitation around the colony shown in Figure 3 (Mayer, Wilson, & Hube, 2013; Park, 348 
Do, & Jung, 2013). This activity was in agreement with previous studies in which C. 349 
albicans produced this enzyme (Deorukhkar et al., 2014; Ramesh et al., 2011; Yang, 350 
2003). Lack of phospholipase production by kefir grain yeasts isolates make them safe 351 
in respect to this enzyme as it  is associated with yeast virulence (Ramesh et al., 2011). 352 
3.6.2. Hemolytic activity 353 
All the kefir yeast isolates and S. boulardii strains produced low levels of alpha 354 
hemolysins comparable to C. albicans as shown in Figure 4. However, only C. albicans 355 
produced weak beta-hemolysis on further incubation up to 72 hours, as illustrated by 356 
greenish-black halo around the colony (Figure 5E). Similar findings have been 357 
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reported previously in which C. albicans produced beta hemolysis after 48 hours 358 
incubation (Luo et al., 2001). Mammalian systems lack free iron which is essential for 359 
microbial proliferation and pathogenesis. Some pathogenic microorganisms possess 360 
hemolysins which assist with breakdown of hemoglobin in order to access 361 
hemoglobin-bound iron (Luo et al., 2001). Hemolysins are either proteinaceous 362 
enzymes or non-proteinaceous toxins which cause cell lysing. The mechanism involve 363 
creating a pore in the cell membrane. Fungal hemolysins are reported to act slowly on 364 
cells resulting in cell death (Vesper & Jo Vesper, 2004).  Alpha hemolysin in the blood 365 
may cause partial breakdown of red blood cells whereas beta hemolysin breakdown 366 
cells completely (Vesper & Jo Vesper, 2004). Histamine release induced by E.coli 367 
alpha hemolysin through immunomodulation was reported in rat model (Gross-368 
Weege, König, Scheffer, & Nimmich, 1988; Scheffer, König, Braun, & Goebel, 1988). 369 
The production of alpha hemolysin by the isolates, is an important property which may 370 
be employed to fight infection by pathogenic bacteria. 371 
3.6.3.  Proteolytic activity 372 
All kefir yeast isolates and controls showed very weak proteolytic activity shown in 373 
Figure 5. Proteolytic enzymes are associated with active entry of pathogens into the 374 
host tissue (Mayer et al., 2013; Sacristan et al., 2011). However, production of 375 
proteolytic enzymes by yeasts may provide prophylactic and therapeutic benefits to 376 
the host as S. boulardii serine protease has been reported to break down Clostridium 377 
difficile and Clostridiums perfringens toxins (Czerucka et al., 2007; Hudson et al., 378 
2016; Palma et al., 2015). Therefore, production of proteolytic enzymes may protect 379 
host against infections by toxins produced by enteropathogenic bacteria such as 380 
Salmonella, Vibrio, Clostridiums, E.coli and Bacillus species (Gut et al., 2018). 381 
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3.7.  Identification of yeast isolates 382 
The yeast isolates from two traditional kefir grains showed potential probiotic 383 
properties and after identification and characterization, two phylogenetic trees were 384 
obtained as shown in Figure 6. A phylogenetic tree by definition shows evolutionary 385 
relationships among species (Mooers & Heard, 1997).  Isolates HSK18099-11 and 386 
TVR18099-12 were identified as Saccharomyces unisporus ATCC 10612 (S. 387 
unisporus) and Kluyveromyces lactis var. lactis ATCC 56498 (K. lactis) 388 
/Kluyveromyces marxinus ATCC16045 (K. marxinus) respectively. The first part of 389 
the figure shows a good separation of S. unisporus from its evolutionarily related 390 
species including Kazachstania africana, Saccharomyces cerevisiae and 391 
Saccharomyces bayanus. Therefore, further differentiation identification method was 392 
not required. However in a previous study S. unisporus isolated from Tibetan kefir 393 
grains could not be differentiated from Kazachstania unisporus and Kazachstania 394 
exigua using 26s rDNA (Zhou, Liu, Jiang, & Dong, 2009). On the other hand, the 395 
second part of the figure showed close similarity between K. lactis and K. marxinus, 396 
which were not effectively differentiated using 26s ribosomal DNA. This was in 397 
agreement with a previous study in which two Kluyveromyces species could not be 398 
differentiated on the basis of their amino acid sequence (Lertwattanasakul et al., 399 
2015). However, in another study, it was reported that K. lactis and K. marxinus were 400 
clearly separated and identified from kefir grain using 26s rDNA (Zhou et al., 2009). 401 
The TVR18099-12 colonies labelled as K. lactis/K. marxinus by 26s rDNA (Figure 6) 402 
were further analyzed using ITS sequencing, and identified as K. lactis ATCC 56498. 403 
ITS sequencing was used successfully to identify Kluyveromyces species and strain 404 
levels in previous study (Belloch, Barrio, García, & Querol, 1998). 405 
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The isolation and identification of culturable yeasts species in the two traditional grains 406 
were consistent with a FAO  report which states that kefir grain contains 407 
Saccharomyces unisporus and Kluyveromyces species, Saccharomyces cerevisiae, 408 
Issatchenkia occidentalis (Diosma, Romanin, Rey-Burusco, Londero, & Garrote, 409 
2014; Magalhães, Pereira, Campos, Dragone, & Schwan, 2011).  410 
3.8. Antibacterial properties 411 
3.8.1. Bacterial growth inhibition 412 
K. lactis and the controls slabs on the lawn and well diffusion assay showed no growth 413 
inhibition of indicator enteric bacteria, however S. unisporus showed weak growth 414 
inhibition of E.coli and E. aerogenes just under the slab (figure not shown). The 415 
controls results are consistent with previous study in which S. boulardii did not inhibit 416 
some gram negative enteropathogenic bacteria growth when tested using this method 417 
(K. Rajkowska, Kunicka-Styczyńska, & Rygala, 2012). Both control and kefir yeast 418 
isolates supernatants showed no growth inhibition effects (picture not shown). There 419 
are controversies on bacteriostatic and bactericidal effects of Saccharomyces species 420 
including the controls and S. unisporus (K. Rajkowska et al., 2012), and the fact that 421 
insufficient data on antibacterial properties of K. lactis is available, further in-depth 422 
research is needed.  423 
3.8.2. Adherence of bacteria onto yeasts cells 424 
Adherent of enteric bacteria indicators was analyzed both qualitatively and 425 
quantitatively. Table 4 shows both viable and non-viable kefir isolates and controls 426 
with statistical significant differences. The data above was also supported by slide 427 
agglutinations (figures not shown) and optical microscopic examination as shown in 428 
figure 7. Two mechanisms of adherence of bacteria onto yeast cells are proposed. 429 
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Specific binding using type 1 fimbriae on bacteria such as E.coli, E. aerogenes and 430 
Salmonella cell with mannan oligosaccharides on yeast cells, and non-specific binding 431 
such as electrostatic and hydrophobic (Adegbola & Old, 1985; Pérez-Sotelo et al., 432 
2005; Tiago et al., 2012). These results are consistent with previous results where 433 
E.coli was reported to bind both viable and non-viable S. boulardii and Saccharomyces 434 
cerevisiae UFMG 905. Binding of enteric bacteria onto yeast cells is reported to be 435 
irreversible leading to transient passage of bacteria through GIT. S. boulardii does not 436 
bind to GIT (Gut et al., 2018). The adherence of enteric bacterial pathogen is 437 
postulated to be responsible for probiotic effects such as inhibition of signalling 438 
transduction pathway activation and subsequent translocation (Tiago et al., 2012) and 439 
hence their prophylactic and therapeutic application in human (Gut et al., 2018), and 440 
animal husbandry to promote health possibly through reduction of infection (Perez-441 
Sotelo et al., 2005). Survival in GIT of these yeast isolates as shown in this study may 442 
lead to increased numbers, and hence increase capacities to scavenge (adhered 443 
bacterial cells) potential pathogenic gram negative enteric bacteria from the gut and 444 
subsequent flushing out in the feces. Moreover, since these yeasts survive in GIT and 445 
are not affected by antibiotics (for example, not affected by Chloramphenicol in this 446 
study, data not shown) aimed at bacteria, their use as complementary therapy with 447 
antibiotics during enteric bacterial infection may also improve treatment through 448 
increased numbers and subsequent mopping out enteric bacteria from the GIT. 449 
Furthermore, the binding of opportunistic enteric bacteria onto non-viable yeasts is of 450 
great significance since consumption of viable yeast probiotics is associated with 451 
fungemia especially in immunocompromised individual or those with GIT issues (Gut 452 
et al., 2018). 453 
 454 
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 455 
4. Conclusion and future perspective 456 
The two traditional kefir grains contained yeasts with potential probiotic properties. GIT 457 
survival, hydrophobicity, auto-aggregation and hydrolytic enzymes production of kefir 458 
yeast isolates was comparable to S. boulardii strains. Both kefir yeast isolates and S. 459 
boulardii produced weak alpha hemolytic and proteolytic activities, but none produce 460 
phospholipases at 30 °C. None of the yeasts produced hydrolytic enzymes at 37 °C. 461 
The 2 isolates showed adherence to enteric bacteria comparable to the controls. 462 
However, further in-depth studies are needed to establish their prophylactic and 463 
therapeutic properties. The isolates were identified as S. unisporus and K. lactis.  464 
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Figure 1. HSK18099-11 and TVR18099-12 colonies morphology appearance on Rose 672 
Bengal Chloramphenicol Agar incubated at 25°C for 5 days. 673 
 674 
Figure 2. Traditional kefir grains after incubation at 30°C for 24 hrs and moved to 25°C 675 
in Devon dale UHT full cream milk and washed with sterile water.  676 
 677 
Figure 3.  C. albicans, phospholipase activity in SDA supplemented with 8% egg yolk 678 
and incubated at 30 °C for 5 days A= HSK18099-11, B = MYA 797TM, C = MYA 796TM, 679 
D = TVR18099-12, E = C. albicans. 680 
 681 
Figure 4. Hemolytic activity in SDA supplemented with 7% defibrinated sheep blood 682 
and incubated at 30 °C for 5 days. A= HSK18099-11, B = MYA 797TM, C = MYA 796TM, 683 
D = TVR18099-12, E = C. albicans. 684 
 685 
Figure 5. Proteolytic activity in 16.25 g SDA, 100 mL UHT skim milk, and 100 mL 686 
deionised sterile water and incubated at 30 °C for 5 days. A= HSK18099-11, B = MYA 687 
797TM, C = MYA 796TM, D = TVR18099-12, E = C. albicans 688 
 689 
Figure 6. Phylogenetic tree analysis of 26s rDNA K. lactis/K. marxinus and S. 690 
unisporus obtained by MicroSEQ® D2 LSU rDNA Fungal Identification Kit following 691 
manufacturers protocols. The tree shows evolutionary closeness of the traditional kefir 692 
grain yeasts isolates to the other yeast species.  693 
 694 
Figure 7. Gram stain showing adherence of E.coli and E. aerogenes onto yeasts cell 695 
wall observed under optical Motic microscope at 100x magnification. A = E. aerogenes 696 
plus K. lactis, B = E.aerogenes plus S.unisporus, C = E. aerogenes plus MYA 796TM, 697 
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D = E. aerogenes plus MYA 797TM, E = E.coli plus K. lactis, F = E.coli plus S. 698 
unisporus, G = E. coli plus MYA 796TM and H = E. coli plus MYA 797TM. 699 
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Tables 746 
 747 
Table 1.  Traditional kefir grains morphological and numerical characterization 748 
Yeast strains TVR18099-12 HSK18099-11 
Colony 
morphology 
White centre with 
pink edge, convex 
and round 
Round smooth, shiny pink and 
convex colonies 
Cellular 
morphology 
Globose to 
ellipsoidal 
unicellular and 
some budding 
 
Globose to ellipsoidal, 
unicellular and budding 
Count in grain 
Log10 cfu /g 
5.4  6.28  
Count in Kefir 
Log10 cfu /g 
6.05  5.81  
 Mean SD (SE) = 0.05 749 
 750 
Table 2. Yeasts isolates probiotics properties 751 
Yeast strains Initial mean 
count (Log10 
cfu /mL)- T0 a 
GIT 
survival 
(Log10 cfu 
/mL) - T1 a  
Decrease 
in viability 
(Log10 cfu 
/mL) - T2a 
Growth at  
37 °C 
Hydrophobicity 
(% index)b 
Auto-
aggregation 
(% index)c 
TVR18099-12 7.06  6.82  0.24 +++ 88.75 35.48 
HSK18099-11 6.80  6.54  0.26 - 30.00 43.33 
MYA 796TM 7.04 6.95  0.09 +++ 15.58 42.86 
MYA 797TM 7.07  6.66  0.41 +++ 21.18 30.59 
-  = no growth; +++ = very good growth; a is standard error mean for GIT = 0.06; b is 752 
standard error mean for hydrophobicity = 0.03; c is standard error mean for auto-753 
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aggregation= 0.03. MYA 796TM and MYA 797TM are two strains of S. boulardii 754 
corresponding to SB48 and SB49 respectively. The difference between GIT treated 755 
and untreated counts for both isolates and controls are statistically significant. 756 
 757 
Table 3. Hydrolytic enzymes activity of yeasts  758 
Yeast strains Hemolytic activity1 Proteolytic 
activity2 
 
Phospholipase 
production3 
α-
hemolysis 
β-
hemolysis 
TVR18099-12 0.90 1 0.92 1 
TVR18099-11 0.76 1 0.67 1 
MYA 796TM 0.77 1 0.78 1 
MYA 797T 0.84 1 0.82 1 
Calb 0.78 0.94 0.76 0.72 
Pz = diameter of colony to the colony plus clearing/precipitation diameter ratio; high, 759 
Pz < 0.40; medium, Pz = 0.41–0.60; low, Pz = 0.61–0.99; none, Pz = 1. Calb = Candida 760 
albicans; 1 is Hemolytic activity Mean SD (SE) = 0.01; 2 is proteolytic activity Mean SD 761 
(SE) = 0.02; 3 is phospholipases activity SEM = 0.02. MYA 796TM and MYA 797TM are 762 
two strains of S. boulardii corresponding to SB48 and SB49 respectively. Calb = 763 
Candida albicans. 764 
 765 
 766 
 767 
 768 
 769 
 770 
 771 
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Table 4. Adhesion and sedimentation assay 772 
Viable yeasts Non-viable 
Indicator 
bacteria 
Control MYA 
796TM 
MYA 
797TM 
KL SU Control MYA 
796TM 
MYA 
797TM 
KL SU 
E. aerogenes 9.05 8.08 8.29 8.47 8.46 8.85 8.18 8.23 8.31 8.34 
E. coli  8.89 8.29 8.52 8.50 8.69 8.73 8.38 8.42 8.39 8.48 
The indicator bacterial count in supernatants of yeasts-bacteria mixture are statistically 773 
lower compare to the control (Paired T sample t-test, p <0.05). Mean SD (SE), 0.03 774 
 775 
 776 
